The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The carcinogenicity of human papillomavirus types reflects viral evolution
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the presence of the E5 gene in the viral genome correlates with the carcinogenic potential [27,30]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
Self-citationPersistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia
Schlecht, N. F. (2001) · JAMA · doi:10.1001/jama.286.24.3106 · Cited by 590
Research works printed but not linked: 32
- Andersson, 2001, The role of human papillomavirus in cervical adenocarcinoma carcinogenesis, Eur. J. Cancer, 37, 246, 10.1016/S0959-8049(00)00376-2 · DOI
- Bosch, 2003, Chapter 1: Human papillomavirus and cervical cancer–burden and assessment of causality, J. Natl. Cancer Inst. Monogr. No., 31, 3, 10.1093/oxfordjournals.jncimonographs.a003479 · DOI
- Bosch, 2002, The causal relation between human papillomavirus and cervical cancer, J. Clin. Pathol., 55, 244, 10.1136/jcp.55.4.244 · DOI
- Bratti, 2004, Description of a seven-year prospective study of HPV infection and cervical neoplasia among 10,000 women in Guanacaste, Costa Rica. J. P. A. H. O., 15, 75
- Castle, 2002, Comparisons of HPV DNA detection by MY09/11 PCR methods, J. Med. Virol., 68, 417, 10.1002/jmv.10220 · DOI
- Castle, P.E., Schiffman M., Herrero R., Hildesheim A., Rodriguez A.C., Bratti C., Sherman M.E., Wacholder S., Tarone R., Burk R.D., in press. A prospective study of age trends in cervical HPV acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis.
- de Villiers, 2004, Classification of papillomaviruses, Virology, 324, 17, 10.1016/j.virol.2004.03.033 · DOI
- DiMaio, 2001, Mechanisms of cell transformation by papillomavirus E5 proteins, Oncogene, 20, 7866, 10.1038/sj.onc.1204915 · DOI
- Fehrmann, 2003, Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation, Oncogene, 22, 5201, 10.1038/sj.onc.1206554 · DOI
- Gravitt, 2000, Improved amplification of genital human papillomaviruses, J. Clin. Microbiol., 38, 357, 10.1128/JCM.38.1.357-361.2000 · DOI · Paper page
- Herrero, 1997, Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project, Rev. Panam. Salud Publica, 1, 362, 10.1590/S1020-49891997000500005 · DOI
- Herrero, 2000, Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica, J. Natl. Cancer Inst., 92, 464, 10.1093/jnci/92.6.464 · DOI · Paper page
- Herrero, 2003, Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study, J. Natl. Cancer Inst., 95, 1772, 10.1093/jnci/djg107 · DOI
- Ho, 1995, Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia, J. Natl. Cancer Inst., 87, 1365, 10.1093/jnci/87.18.1365 · DOI
- Huelsenbeck, 2004, MRBAYES: Bayesian inference of phylogenetic trees, Bioinformatics, 17, 754, 10.1093/bioinformatics/17.8.754 · DOI · Paper page
- Kashima, 1996, Recurrent respiratory papillomatosis, Obstet. Gynecol. Clin. North Am., 23, 699
- Kell, 1994, Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides, J. Gen. Virol., 75, 2451, 10.1099/0022-1317-75-9-2451 · DOI · Paper page
- Koutsky, 2002, A controlled trial of a human papillomavirus type 16 vaccine, N. Engl. J. Med., 347, 1645, 10.1056/NEJMoa020586 · DOI
- Lowy, 2003, Chapter 16: Prophylactic human papillomavirus vaccines, J. Natl. Cancer Inst. Monogr. No., 31, 111, 10.1093/oxfordjournals.jncimonographs.a003472 · DOI
- Molano, 2003, Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study, Am. J. Epidemiol., 158, 486, 10.1093/aje/kwg171 · DOI
- Munoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N. Engl. J. Med., 348, 518, 10.1056/NEJMoa021641 · DOI · Paper page
- Nobbenhuis, 1999, Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study, Lancet, 354, 20, 10.1016/S0140-6736(98)12490-X · DOI
- Qu, 1997, PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems, J. Clin. Microbiol., 35, 1304, 10.1128/jcm.35.6.1304-1310.1997 · DOI
- Richardson, 2003, The natural history of type-specific human papillomavirus infections in female university students, Cancer Epidemiol. Biomarkers Prev., 12, 485
- Schiffman, 2003, Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia, J. Natl. Cancer Inst. Monogr. No., 31, 14, 10.1093/oxfordjournals.jncimonographs.a003476 · DOI
- Schiffman, 2000, Human papillomavirus testing as a screening tool for cervical cancer, JAMA, 283, 2525, 10.1001/jama.283.19.2525 · DOI
- Stoler, 2001, Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study, JAMA, 285, 1500, 10.1001/jama.285.11.1500 · DOI · Paper page
- Van Ranst, 1992, Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations, J. Gen. Virol., 73, 2653, 10.1099/0022-1317-73-10-2653 · DOI
- Wang, 2003, Chapter 5: Viral and host factors in human papillomavirus persistence and progression, J. Natl. Cancer Inst. Monogr. No., 31, 35, 10.1093/oxfordjournals.jncimonographs.a003480 · DOI
- Woodman, 2001, Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study, Lancet, 357, 1831, 10.1016/S0140-6736(00)04956-4 · DOI
- Wright, 2003, 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia, Am. J. Obstet. Gynecol., 189, 295, 10.1067/mob.2003.633 · DOI
- zur Hausen, 2000, Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis, J. Natl. Cancer Inst., 92, 690, 10.1093/jnci/92.9.690 · DOI
Cited by
Chapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355
Carrageenan is a potent inhibitor of papillomavirus infection
Buck, C. B., Thompson, C. D., Roberts, J. N., Müller, M., Lowy, D. R., & Schiller, J. T. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020069 · Cited by 497
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Machalek, D. A., Grulich, A. E., Jin, F., Templeton, D. J., & Poynten, I. M. (2012) · Sexual Health · doi:10.1071/sh12043 · Cited by 59
Metadata
- Authors
- Schiffman, M., Herrero, R., DeSalle, R., Hildesheim, A., Wacholder, S., Cecilia Rodriguez, A., Bratti, M. C., Sherman, M. E., Morales, J., Guillen, D., Alfaro, M., Hutchinson, M., Wright, T. C., Solomon, D., Chen, Z., Schussler, J., Castle, P. E., & Burk, R. D.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 337
- Issue
- 1
- Pages
- 76-84
- ISSN
- 0042-6822
- Cited by
- 441
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The carcinogenicity of human papillomavirus types reflects viral evolution. https://app.cochat.ai/papers/10.1016/j.virol.2005.04.002
- The paper
- Schiffman, M., Herrero, R., DeSalle, R., Hildesheim, A., Wacholder, S., Cecilia Rodriguez, A., Bratti, M. C., Sherman, M. E., Morales, J., Guillen, D., Alfaro, M., Hutchinson, M., Wright, T. C., Solomon, D., Chen, Z., Schussler, J., Castle, P. E., & Burk, R. D. (2005). The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. https://doi.org/10.1016/j.virol.2005.04.002